ZA937068B - Use of hyaluronic acid and forms to prevent arterial restenosis - Google Patents

Use of hyaluronic acid and forms to prevent arterial restenosis

Info

Publication number
ZA937068B
ZA937068B ZA937068A ZA937068A ZA937068B ZA 937068 B ZA937068 B ZA 937068B ZA 937068 A ZA937068 A ZA 937068A ZA 937068 A ZA937068 A ZA 937068A ZA 937068 B ZA937068 B ZA 937068B
Authority
ZA
South Africa
Prior art keywords
forms
hyaluronic acid
arterial restenosis
prevent arterial
prevent
Prior art date
Application number
ZA937068A
Other languages
English (en)
Inventor
Rudolf Edgar Falk
Samuel Simon Asculai
Eva Anne Turley
Original Assignee
Norpharmco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norpharmco Inc filed Critical Norpharmco Inc
Publication of ZA937068B publication Critical patent/ZA937068B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
ZA937068A 1992-09-25 1993-09-24 Use of hyaluronic acid and forms to prevent arterial restenosis ZA937068B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002079205A CA2079205C (en) 1992-09-25 1992-09-25 Use of hyaluronic acid and forms to prevent arterial restenosis

Publications (1)

Publication Number Publication Date
ZA937068B true ZA937068B (en) 1994-04-18

Family

ID=4150463

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA937068A ZA937068B (en) 1992-09-25 1993-09-24 Use of hyaluronic acid and forms to prevent arterial restenosis

Country Status (26)

Country Link
EP (1) EP0661981B1 (xx)
JP (1) JP3742955B2 (xx)
CN (1) CN1057908C (xx)
AP (1) AP448A (xx)
AT (1) ATE141054T1 (xx)
AU (1) AU670117B2 (xx)
BR (1) BR9307221A (xx)
CA (1) CA2079205C (xx)
CZ (1) CZ288986B6 (xx)
DE (1) DE69303931T2 (xx)
DK (1) DK0661981T3 (xx)
ES (1) ES2091031T3 (xx)
GR (1) GR3021171T3 (xx)
HK (1) HK35397A (xx)
HU (2) HU227067B1 (xx)
IL (1) IL107087A0 (xx)
IN (1) IN181289B (xx)
MD (1) MD960294A (xx)
MX (1) MX9305887A (xx)
NO (1) NO309457B1 (xx)
NZ (1) NZ255978A (xx)
PL (1) PL308201A1 (xx)
SG (1) SG48845A1 (xx)
SK (1) SK36895A3 (xx)
TW (1) TW271401B (xx)
ZA (1) ZA937068B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
EP1005874B1 (en) * 1997-08-22 2005-05-18 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid gel, process for producing the same and medical material containing the same
FR2813791B1 (fr) 2000-09-14 2004-03-12 Lafon Labor Utilisation de 2- et 4-quinolones pour inhiber la neo-proliferation intimale
FR2994846B1 (fr) 2012-08-29 2014-12-26 Vivacy Lab Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease

Also Published As

Publication number Publication date
HUT73637A (en) 1996-08-28
CN1057908C (zh) 2000-11-01
SG48845A1 (en) 1998-05-18
HU227067B1 (en) 2010-06-28
CZ288986B6 (cs) 2001-10-17
HU211698A9 (en) 1995-12-28
JP3742955B2 (ja) 2006-02-08
SK36895A3 (en) 1997-03-05
DK0661981T3 (da) 1996-12-23
AP448A (en) 1996-01-18
HK35397A (en) 1997-03-27
IL107087A0 (en) 1993-12-28
BR9307221A (pt) 1999-07-27
MD960294A (ro) 1997-10-31
AP9300568A0 (en) 1993-10-31
DE69303931T2 (de) 1997-01-09
AU4812693A (en) 1994-04-26
TW271401B (xx) 1996-03-01
EP0661981A1 (en) 1995-07-12
JPH08506797A (ja) 1996-07-23
NO951122D0 (no) 1995-03-23
NO309457B1 (no) 2001-02-05
AU670117B2 (en) 1996-07-04
EP0661981B1 (en) 1996-08-07
ATE141054T1 (de) 1996-08-15
CZ66295A3 (en) 1996-02-14
NZ255978A (en) 1997-02-24
CA2079205A1 (en) 1994-03-26
IN181289B (xx) 1998-05-02
CA2079205C (en) 1998-02-10
PL308201A1 (en) 1995-07-24
MX9305887A (es) 1994-05-31
CN1092654A (zh) 1994-09-28
HU9500857D0 (en) 1995-05-29
ES2091031T3 (es) 1996-10-16
GR3021171T3 (en) 1996-12-31
DE69303931D1 (de) 1996-09-12
NO951122L (no) 1995-03-23

Similar Documents

Publication Publication Date Title
HK1005985A1 (en) Combined use of hyaluronic acid and therapeutic agents to improve the therapeutic effect
EP0724436A4 (en) NITRIC OXIDE ADDITION PRODUCTS FOR THE PREVENTION OF THROMBOSIS ON ARTIFICIAL AND VASCULAR SURFACES
EP0752885A4 (en) THERAPEUTIC INHIBITOR OF SMOOTH VASCULAR MUSCLE CELLS
AP9300492A0 (en) Treatment of disease employing hyaluronic acid and nsaids
EP0532466A3 (en) Derivatives of 5-amino-4-hydroxy-hexanoic acid and their therapeutical use
SG43170A1 (en) Derivatives and analogues of 2-deoxy-2 3-didehydro-n- acetyl neuraming acid and their use as antiviral agents
IL81877A0 (en) Heavy metal salts of hyaluronic acid and their use as antimicrobial agents
HU9202085D0 (en) Derivatives of 7-isoindolinyl-quinolone and of naphthyridone-carboxylic acid
AU6422294A (en) Use of hyaluronic acid and forms to prevent arterial restenosis
GB9208921D0 (en) Electrochemical treatment of surfaces
EG18822A (en) Production and use of prophyrins
ZA931489B (en) Use of interleuken-10 to suppress graft-vs-host disease
GB2283403B (en) Improvements in and relating to treatment of meat
EP0506976A4 (en) Combination of hyaluronic acid with medicinal ingredient and production thereof
ZA937068B (en) Use of hyaluronic acid and forms to prevent arterial restenosis
EP0446852A3 (en) Use of polyglycolic acid and its derivatives as nucleating agent
ZA938898B (en) Use of certain methanebisphosphonic acid derivatives in fracture healing
EP0519763A3 (en) Cyclohexylbutyric acid derivatives and their use in the production of optically active cyclohexylnorstatine
AU7022496A (en) Use of hyaluronic acid and forms to prevent arterial restenosis
EP0444931A3 (en) Use of 3-oxygermylpropionic acid to treat and prevent diabetes-dependent autoimmune diseases
ZA936136B (en) Treatment of skin diseases
GB2266241B (en) Treatment of pastures
GB9216360D0 (en) Treatment of blood
EP0456204A3 (en) Use of benzocycloheptathiophenecarboxylic acid derivatives in the treatment of eosinophile accumulation/activation and connected diseases
IL85818A0 (en) Complexes of hyaluronic acid and therapeutic compositions containing the same